JMCP Award for Excellence

DESCRIPTION: 
The Journal of Managed Care + Specialty Pharmacy (JMCP) Award for Excellence was established in 2002 to recognize an article that represents the best scholarly work in managed care pharmacy.

CRITERIA:
Articles considered for nomination must have been published in JMCP in the calendar year prior to the award presentation.

NOMINATION PROCESS:
Each member of the JMCP Editorial Advisory Board may nominate one (1) or two (2) articles for consideration with justification for each nomination. One article is selected. Honorable Mentions may be given.

Send Your Nomination

SELECTION PROCESS:
A 7-member panel of judges is convened each year that is comprised of three (3) members of the JMCP Editorial Advisory Board and four (4) JMCP Peer Reviewers who have contributed high-quality reviews. The nominated articles are evaluated by the Judges Panel according to the following measures:

  • Impact on the profession or knowledge/thought leadership.
  • Relevance to managed care pharmacy today.
  • Scientific merit and sound methodology.
  • Clarity of purpose and hypothesis.
  • Writing quality and readability.

NATURE OF AWARD:

The JMCP Award for Excellence is presented at the AMCP Annual Meeting. The recipient receives a plaque, complimentary registration to the AMCP Annual Meeting, travel reimbursement (up to $1,000) for one author to receive the award. 

PAST RECIPIENTS:
For articles published in:

  • 2023
    Underprescribing vs underfilling to oral anticoagulation: An analysis of linked medical record and claims data for a nationwide sample of patients with atrial fibrillation. Authors: Jingchuan Serena Guo, MD, PhD; Meiqi He, MS; Nico Gabriel, MS; Jared W Magnani, MD, MSc; Stephen E Kimmel, MD, MSCE; Walid F Gellad, MD, MPH; Inmaculada Hernandez, PharmD, PhD 
  • 2022
    Association of 3 CDC Opioid Prescription Guidelines for Chronic Pain and 2 Payer Pharmacy Coverage Changes on Opioid Initiation Practices. Authors: Adeniyi T. Togun, MD, MPH, MS, PhD; Pinar Karaca-Mandic, PhD; Rebecca Wurtz, MD, MPH; Molly Moore Jeffery, PhD; Timothy Beebe, MA, PhD 
  • 2020
    Racial/Ethnic and Gender Disparities in the Use of Erythropoiesis-Stimulating Agents and Blood Transfusions: Cancer Management Under Medicare’s Reimbursement Policy. Authors: Minghui Li, PhD; Richard Schulz, PhD; Marie Chisholm-Burns, PharmD; Junling Wang, PhD; and Z. Kevin Lu, PhD
  • 2019
    Actionable Real-World Evidence to Improve Health Outcomes and Reduce Medical Spending Among Risk-Stratified Patients with Diabetes. Authors: Elizabeth M. Garry, PhD, MPH; Sebastian Schneeweiss, MD, ScD; Sara Eapen, PhD; Natalia Petruski-Ivleva, PhD, MS; Elizabeth Cheever, MS; William Murk, PhD, MPH; Aditya Rajan, MPH; Jeremy A. Rassen, ScD; David Gambino, MS; Hannah Jang, PharmD; Elizabeth Rubin, MPA; and Saira Jan, MS, PharmD. . 
    • Honorable Mention: Evaluation of a Pharmacist-Managed Antidiabetic Deprescribing Program in an Integrated Health Care System. Authors: Rita L. Hui, PharmD, MS; Christopher C. Chang, PharmD, BCGP; Fang Niu, MS; Yen K. Tang, PharmD, BCPS; Denise Harano, PharmD, BCPS, BCGP; Lynn Deguzman, PharmD, BCGP; Doris J. Kao, PharmD, BCPS; Sameer Awsare, MD; and Maisha Draves, MD, MPH
  • 2018
    Development of Quality Indicators to Assess Oral Anticoagulant Management in Community Pharmacies for Patients with Atrial Fibrillation. Authors: Chartrand M, Guenette L, Brouilette D, et al.
  • 2017
    Using Performance-Based Risk-Sharing Arrangements to Address Uncertainty in Indication-Based Pricing. Authors: Kai Yeung, PharmD, PhD,  Meng Li, ScM , and Josh J. Carlson, PhD, MPH
  • 2016
    Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia. Authors:  Joanna P. MacEwan, PhD,  Felicia M. Forma, BSc, Jason Shafrin, PhD, Ainslie Hatch, PhD, Darius N. Lakdawalla, PhD, Jean-Pierre Lindenmayer, MD
  • 2015
    Improving the Efficiency and Quality of the Value Assessment Process for Companion Diagnostic Tests: The Companion Test Assessment Tool (CAT). Authors: William J. Canestaro, Louis P. Garrison, David L. Veenstra, Daryl E. Pritchard, Robert Dubois.
  • 2014
    Is There an Association Between the High-Risk Medication Star Ratings and Member Experience CMS Star Ratings Measure? Authors: Sara Carruth Erickson, R. Scott Leslie, Bimal V. Patel.
  • 2013
    The Effect of Hepatitis C Treatment Response on Medical Costs:  A Longitudinal Analysis in an Integrated Care Setting. Authors:  M. Michel Manos, Jeanne Darbinian, Jaime Rubin, G. Thomas Ray, Valentina Shvachko, Baris Denis, Futon Velez, Charles Qusenberry.
  • 2012
    Evaluation of a program to improve diabetes care through intensified care management activities and diabetes medication copayment reduction. Authors:  Stephen J. Kogut, Brian J. Quilliam, Scott Johnson and Tara Higgens.
  • 2011 
    Discontinuation Rates and Health Care Costs in Adult Patients Starting Generic Versus Brand SSRI or SNRI Antidepressants in Commercial Health Plans. Authors:  Anna Vlahiotis, Scott Devine, Jeff Eichholz, Adam Kautzner.
  • 2010  
    Addition of Generic Medication Vouchers to a Pharmacist Academic Detailing Program: Effects on the Generic Dispensing Ratio in a Physician-Hospital Organization. Authors: Vinay Bhargava, Mark E. Greg, Mark C. Shields.
  • 2009  
    Association of Prescription Abandonment with Cost Share for High-Cost Specialty Pharmacy. Authors: Patrick P. Gleason, Catherine I. Starner, Brent Gundeson, and Jeremy Schafer.  One Honorable Mention was also given.
  • 2008  
    Rosiglitazone and Piolitazone Utilization from January 2007 through May 2009 Associated with Five Risk-Warning Events. Authors: Catherine I. Starner, Jeremy A. Schafer, and Patrick P. Gleason and Alan Heaton. One Honorable Mention was also given.
  • 2007    
    Comparison of Mail-Order with Community Pharmacy in Plan Sponsor Cost and Member Cost in Two Large Pharmacy Benefit Plans. Authors: Michael Johnsrud, Kenneth A. Lawson, and Marvin D. Shepherd. Two Honorable Mentions were also given.
  • 2006    
    Analysis of the Effectiveness and Cost Benefit of Leukotriene Modifiers in Adults with Asthma in the Ohio Medicaid Population. Authors: Pamela Heaton, Jeff J. Guo, Richard W. Hornung, Joseph A. Johnston, Raymon Jang, Charles J. Moomaw, and Robert Cluxton all, except Johnston, are with University of Cincinnati. Johnston was with the University of Cincinnati Medical Center. Two Honorable Mentions were also given.
  • 2005  
    Product-Line Extensions and Pricing Strategies of Brand-Name Drugs Facing Patent Expiration. Authors: Son Hee Hong, Marvin D. Shepherd, David Scoones, and Thomas T.H. Wan.  Two Honorable Mentions were also given.
  • 2004    
    Randomized Controlled Trial of a Dose Consolidation Program. Authors: Thomas Delate, Kathleen A. Fairman, Shell Carey, and Brenda Motherall.           
  • 2003    
    Do Decision-Analytic Models Identify Cost-Effective Treatments? A Retrospective Look at Helicobacter Pylori Eradication. Authors: Kathleen A. Fariman and Brenda Motheral. Two Honorable Mentions were also given.
  • 2002    
    Effects of a Tablet-Splitting Program in Patients Taking HMG-CoA Reductase Inhibitors: Analysis of Clinical Effects, Patient Satisfaction, Compliance and Cost Avoidance. Authors: Michael Gee, Noelle K. Hasson, Terri Jahn, and Russell Ryono.  Two Honorable Mentions were also given.